Politics Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly Finance News Feb 23, 2026 The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |… Read More...
Business Novo Nordisk faces defining year in the obesity drug market Finance News Feb 16, 2026 Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the White… Read More...
Politics Novo Nordisk sues Hims & Hers over compounded obesity drugs Finance News Feb 9, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen,… Read More...
Politics Novo Nordisk stock rises; Hims & Hers pulls copycat weight-loss pill Finance News Feb 9, 2026 Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the… Read More...
Politics Hims & Hers announces Wegovy pill copy; Novo Nordisk vows legal action Finance News Feb 5, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen,… Read More...
Politics Novo Nordisk stock tumbles after FY earnings, sales forecast Finance News Feb 3, 2026 Novo Nordisk signage on the floor of the New York Stock Exchange in New York, US, on Friday, Jan. 2, 2026.Michael… Read More...
Politics Novo Nordisk shares rise after Wegovy obesity pill launch Finance News Jan 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan. 15, 2026. George Frey… Read More...
Politics 2026 is the year of obesity pills from Novo Nordisk, Eli Lilly Finance News Jan 10, 2026 The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next… Read More...
Politics First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. Finance News Jan 5, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts… Read More...
Politics Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026 Finance News Jan 1, 2026 Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by:… Read More...